CORMEDIX INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
CORMEDIX INC. (CRMD) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $676.61 thousand for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-11.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2020-05-11
- CORMEDIX INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2020-03-31 was $676.61K, a 16.40% decline year-over-year.
- CORMEDIX INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2019-12-31 was -$453.34K.
- CORMEDIX INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2019-09-30 was -$570.61K.
- CORMEDIX INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2019-06-30 was -$606.33K.
- CORMEDIX INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2019 was -$2.44M.
- CORMEDIX INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2018 was -$1.11M.
- CORMEDIX INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2017 was -$1.66M.
- CORMEDIX INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2016 was -$1.34M.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month as first filed | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 5 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|---|---|
| 2020-03-31 | $676.61K 10-Q · filed 2020-05-11 | $223.27K derived: sum of 2 quarters · filed 2020-05-11 | -$347.34K derived: sum of 3 quarters · filed 2020-05-11 | -$953.67K derived: sum of 4 quarters · filed 2020-05-11 | ||
| 2019-12-31 | -$453.34K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -$1.02M derived: sum of 2 quarters · filed 2020-03-16 | -$1.63M derived: sum of 3 quarters · filed 2020-03-16 | -$2.44M 10-K · filed 2020-03-16 | ||
| 2019-09-30 | -$570.61K 10-Q · filed 2019-11-14 | -$1.18M derived: sum of 2 quarters · filed 2019-11-14 | -$1.99M 10-Q · filed 2019-11-14 | -$386.63K derived: sum of 4 quarters · filed 2020-05-11 | ||
| 2019-06-30 | -$606.33K 10-Q · filed 2019-08-14 | $203.00K derived: sum of 2 quarters · filed 2020-05-11 | $183.98K derived: sum of 3 quarters · filed 2020-05-11 | -$176.16K derived: sum of 4 quarters · filed 2020-05-11 | ||
| 2019-03-31 | $809.33K 10-Q · filed 2020-05-11 | -$809.33K 10-Q · filed 2019-05-13 | $790.31K derived: sum of 2 quarters · filed 2020-05-11 | $430.17K derived: sum of 3 quarters · filed 2020-05-11 | $71.99K derived: sum of 4 quarters · filed 2020-05-11 | |
| 2018-12-31 | -$19.02K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -$379.16K derived: sum of 2 quarters · filed 2020-03-16 | -$737.34K derived: sum of 3 quarters · filed 2020-03-16 | -$1.11M 10-K · filed 2020-03-16 | ||
| 2018-09-30 | -$360.14K 10-Q · filed 2019-11-14 | -$718.32K derived: sum of 2 quarters · filed 2019-11-14 | -$1.09M 10-Q · filed 2019-11-14 | -$1.49M derived: sum of 4 quarters · filed 2019-11-14 | ||
| 2018-06-30 | -$358.18K 10-Q · filed 2019-08-14 | -$731.47K 10-Q · filed 2018-08-14 | -$1.13M derived: sum of 3 quarters · filed 2019-08-14 | -$1.54M derived: sum of 4 quarters · filed 2019-08-14 | ||
| 2018-03-31 | -$373.29K 10-Q · filed 2019-08-14 | -$768.15K derived: sum of 2 quarters · filed 2019-08-14 | -$1.18M derived: sum of 3 quarters · filed 2019-08-14 | -$1.58M derived: sum of 4 quarters · filed 2019-08-14 | ||
| 2017-12-31 | -$394.86K derived: 10-K 12 month − 10-Q 9 month · filed 2019-05-29 | -$809.49K derived: sum of 2 quarters · filed 2019-05-29 | -$1.21M derived: sum of 3 quarters · filed 2019-05-29 | -$1.66M 10-K · filed 2019-05-29 | ||
| 2017-09-30 | -$414.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$812.25K derived: sum of 2 quarters · filed 2017-11-09 | -$1.26M 10-Q · filed 2017-11-09 | -$1.68M derived: sum of 4 quarters · filed 2018-03-19 | ||
| 2017-06-30 | -$397.62K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$849.64K 10-Q · filed 2017-08-09 | -$1.26M derived: sum of 3 quarters · filed 2018-03-19 | -$1.46M derived: sum of 4 quarters · filed 2018-03-19 | ||
| 2017-03-31 | -$452.02K 10-Q · filed 2017-05-10 | -$866.32K derived: sum of 2 quarters · filed 2018-03-19 | -$1.06M derived: sum of 3 quarters · filed 2018-03-19 | -$1.35M derived: sum of 4 quarters · filed 2018-03-19 | ||
| 2016-12-31 | -$414.29K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-19 | -$606.98K derived: sum of 2 quarters · filed 2018-03-19 | -$893.09K derived: sum of 3 quarters · filed 2018-03-19 | -$1.34M 10-K · filed 2018-03-19 | ||
| 2016-09-30 | -$192.68K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$478.80K derived: sum of 2 quarters · filed 2016-11-09 | -$920.86K 10-Q · filed 2016-11-09 | -$1.24M derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2016-06-30 | -$286.11K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$728.18K 10-Q · filed 2016-08-04 | -$1.04M derived: sum of 3 quarters · filed 2017-03-16 | -$1.97M derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2016-03-31 | -$442.07K 10-Q · filed 2016-05-10 | -$758.87K derived: sum of 2 quarters · filed 2017-03-16 | -$1.68M derived: sum of 3 quarters · filed 2017-03-16 | -$2.64M derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2015-12-31 | -$316.80K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | -$1.24M derived: sum of 2 quarters · filed 2017-03-16 | -$2.20M derived: sum of 3 quarters · filed 2017-03-16 | -$3.23M 10-K · filed 2017-03-16 | ||
| 2015-09-30 | -$921.15K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | -$1.88M derived: sum of 2 quarters · filed 2015-11-12 | -$2.91M 10-Q · filed 2015-11-12 | -$3.13M derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2015-06-30 | -$960.78K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | -$1.99M 10-Q · filed 2015-08-06 | -$2.21M derived: sum of 3 quarters · filed 2017-03-16 | -$2.38M derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2015-03-31 | -$1.03M 10-Q · filed 2015-05-07 | -$1.25M derived: sum of 2 quarters · filed 2017-03-16 | -$1.42M derived: sum of 3 quarters · filed 2017-03-16 | -$1.78M derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2014-12-31 | -$226.11K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | -$392.55K derived: sum of 2 quarters · filed 2017-03-16 | -$753.06K derived: sum of 3 quarters · filed 2017-03-16 | -$2.17M 10-K · filed 2017-03-16 | ||
| 2014-09-30 | -$166.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | -$526.95K derived: sum of 2 quarters · filed 2014-11-13 | -$1.94M 10-Q · filed 2014-11-13 | -$2.53M derived: sum of 4 quarters · filed 2015-03-12 | ||
| 2014-06-30 | -$360.51K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | -$1.78M 10-Q · filed 2014-08-14 | -$2.37M derived: sum of 3 quarters · filed 2015-03-12 | -$2.69M derived: sum of 4 quarters · filed 2015-03-12 | ||
| 2014-03-31 | -$1.42M 10-Q · filed 2014-05-15 | -$2.01M derived: sum of 2 quarters · filed 2015-03-12 | -$2.33M derived: sum of 3 quarters · filed 2015-03-12 | -$2.78M derived: sum of 4 quarters · filed 2015-03-12 | ||
| 2013-12-31 | -$591.66K derived: 10-K 12 month − 10-Q/A 9 month · filed 2015-03-12 | -$913.29K derived: sum of 2 quarters · filed 2015-03-12 | -$1.36M derived: sum of 3 quarters · filed 2015-03-12 | -$1.35M 10-K · filed 2015-03-12 | ||
| 2013-09-30 | -$321.63K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2014-03-04 | -$771.40K derived: sum of 2 quarters · filed 2014-03-04 | -$753.48K 10-Q/A · filed 2014-03-04 | -$662.29K derived: sum of 4 quarters · filed 2014-03-04 | ||
| 2013-06-30 | -$449.77K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2014-03-04 | -$431.85K 10-Q/A · filed 2014-03-04 | -$340.67K derived: sum of 3 quarters · filed 2014-03-04 | -$311.86K derived: sum of 4 quarters · filed 2014-03-04 | ||
| 2013-03-31 | $17.92K 10-Q/A · filed 2014-03-04 | $109.10K derived: sum of 2 quarters · filed 2014-03-04 | $137.92K derived: sum of 3 quarters · filed 2014-03-04 | $195.62K derived: sum of 4 quarters · filed 2014-03-04 | ||
| 2012-12-31 | $91.18K derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-03-27 | $119.99K derived: sum of 2 quarters · filed 2013-03-27 | $177.70K derived: sum of 3 quarters · filed 2013-03-27 | $274.36K 10-K · filed 2013-03-27 | ||
| 2012-09-30 | $28.81K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2013-03-27 | $86.52K derived: sum of 2 quarters · filed 2013-03-27 | $183.18K 10-Q/A · filed 2013-03-27 | $341.37K derived: sum of 4 quarters · filed 2013-03-27 | ||
| 2012-06-30 | $57.70K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-06 | $154.37K 10-Q/A · filed 2012-09-06 | $312.55K derived: sum of 3 quarters · filed 2013-03-27 | $415.68K derived: sum of 4 quarters · filed 2013-03-27 | ||
| 2012-03-31 | $96.66K 10-Q · filed 2012-05-15 | $254.85K derived: sum of 2 quarters · filed 2013-03-27 | $357.98K derived: sum of 3 quarters · filed 2013-03-27 | |||
| 2011-12-31 | $158.19K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-27 | $261.32K derived: sum of 2 quarters · filed 2013-03-27 | $692.40K 10-K · filed 2013-03-27 | |||
| 2011-09-30 | $103.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10 | $534.22K 10-Q · filed 2011-11-10 | ||||
| 2011-06-30 | $431.09K 10-Q · filed 2011-08-09 | |||||
| 2010-12-31 | $1.17M 10-K · filed 2013-03-27 | |||||
| 2009-12-31 | $114.14K 10-K · filed 2013-03-27 | |||||
| 2008-12-31 | $281.65K 10-K · filed 2013-03-27 | |||||
| 2007-12-31 | $64.88K 10-K · filed 2013-03-27 | |||||
| 2006-12-31 | $4.73K 10-K · filed 2013-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |